サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1263946

グライコミクス・糖鎖生物学の世界市場：動向、機会、競合分析（2023年～2028年）

Glycomics/Glycobiology Market: Trends, Opportunities and Competitive Analysis [2023-2028]
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

グライコミクス・糖鎖生物学の世界市場：動向、機会、競合分析（2023年～2028年）
出版日: 2023年04月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界のグライコミクス・糖鎖生物学の市場規模は、2028年には36億米ドルになると予測されており、2023年から2028年までの予測期間中のCAGRは14.8%となっています。創薬に関連する調査開発活動の増加、新しいグリコミクスと糖鎖生物学ツールの開発のための学術研究に対する政府や組織による投資の増加は、市場の成長を促進しています。

当レポートでは、世界のグライコミクス・糖鎖生物学市場について調査しており、市場力学、市場動向、企業プロファイルなど、包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界のグライコミクス・糖鎖生物学市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 産業の促進要因と課題

第3章 市場動向と予測分析（2017年～2028年）

  • マクロ経済の動向（2017年～2022年）と予測（2023年～2028年）
  • 世界のグライコミクス・糖鎖生物学市場の動向（2017年～2022年）と予測（2023年～2028年）
  • 世界のグライコミクス・糖鎖生物学市場：製品別
    • 酵素
      • グリコシダーゼ・ノイラミダーゼ
      • グリコシルトランスフェラーゼ・シアリルトランスフェラーゼ
      • その他
    • 機器
      • 質量分析計器
      • クロマトグラフィー機器
      • アレイ
      • その他
    • 炭水化物
      • オリゴ糖
      • 単糖類
      • その他
    • 試薬・薬品
  • 世界のグライコミクス・糖鎖生物学市場：用途別
    • 創薬と開発
    • 疾患診断
      • がん診断
      • その他の疾患診断
    • その他の用途
  • 世界のグライコミクス・糖鎖生物学市場：最終用途産業別
    • 学術・研究機関
    • 製薬・バイオテクノロジー企業
    • 臨床ラボ

第4章 市場動向と予測分析（2017年～2028年）：地域別

  • 世界のグライコミクス・糖鎖生物学市場：地域別
  • 北米のグライコミクス・糖鎖生物学市場
  • 欧州のグライコミクス・糖鎖生物学市場
  • アジア太平洋のグライコミクス・糖鎖生物学市場
  • その他の地域のグライコミクス・糖鎖生物学市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略分析

  • 成長機会分析
    • 世界のグライコミクス・糖鎖生物学市場の成長機会：製品別
    • 世界のグライコミクス・糖鎖生物学市場の成長機会：用途別
    • 世界のグライコミクス・糖鎖生物学市場の成長機会：最終用途産業別
    • 世界のグライコミクス・糖鎖生物学市場の成長機会：地域別
  • 世界のグライコミクス・糖鎖生物学市場における新たな動向
  • 戦略分析
    • 新製品の開発
    • 世界のグライコミクス・糖鎖生物学市場の生産能力拡大
    • 世界のグライコミクス・糖鎖生物学市場における合併、買収、合弁事業
    • 認定とライセンシング

第7章 主要企業プロファイル

  • Merck
  • Agilent
  • Thermo Fisher Scientific
  • New England Biolabs
  • Shimadzu
  • Takara Bio
  • S-BIO
  • Waters
  • Asparia Glycomics
  • Bio-Techne
目次

Glycomics/Glycobiology Market Trends and Forecast

The future of the glycomics/glycobiology market looks promising with opportunities in drug discovery & development and disease diagnostics. The global glycomics/glycobiology market is expected to reach an estimated $3.6 billion by 2028 with a CAGR of 14.8% from 2023 to 2028. The major drivers for this market are increasing research and development activities related to drug discovery along with rising investment by governments and organizations for academic research for development of new glycomics and glycobiology tools.

A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.

Glycomics/Glycobiology Market by Segment

The study includes trends and forecast for the global glycomics/glycobiology market by product, application, end use industry, and region, as follows:

Glycomics/Glycobiology Market by Product [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Enzymes

Glycosidases & Neuramidases

Glycosyltransferases & Sialyltransferases

Others

  • Instruments

Mass Spectrometry Instruments

Chromatography Instruments

Arrays

Others

  • Carbohydrates

Oligosaccharides

Monosaccharides

Others

  • Reagents & Chemicals

Glycomics/Glycobiology Market by Application [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Drug Discovery & Development
  • Disease Diagnostics

Cancer Diagnostics

Others

  • Others

Glycomics/GlycobiologyMarket by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Clinical Laboratories

Glycomics/Glycobiology Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Glycomics/Glycobiology Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, glycomics/glycobiology companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the glycomics/glycobiology companies profiled in this report include-

  • Merck
  • Agilent
  • Thermo Fisher Scientific
  • New England Biolabs
  • Shimadzu
  • Takara Bio
  • S-BIO
  • Waters
  • Asparia Glycomics
  • Bio-Techne

Glycomics/Glycobiology Market Insights

  • Lucintel forecasts that drug discovery and development will remain the largest segment over the forecast period due to the increasing research and development activities related to glycomics and proteomics.
  • Academic and research institutes are expected to remain the largest segment due to the increasing investment in research and development activities and growing adoption of glycan structure data analysis by research centers.
  • North America will remain the largest region due to an increase in government fundings for research and development activities and presence of advanced healthcare infrastructure in the region.

Features of the Glycomics/Glycobiology Market

  • Market Size Estimates:Glycomics/glycobiology market size estimation in terms of value ($B)
  • Trend And Forecast Analysis:Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
  • Segmentation Analysis:Glycomics/glycobiology market size by various segments, such as product, application, end use industry, and region
  • Regional Analysis:Glycomics/glycobiology market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities:Analysis on growth opportunities in different products, applications, end use industries, and regions for the glycomics/glycobiology market.
  • Strategic Analysis:This includes M&A, new product development, and competitive landscape for the glycomics/glycobiology market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the glycomics/glycobiology market size?

Answer: The global glycomics/glycobiology market is expected to reach an estimated $3.6 billion by 2028.

Q2. What is the growth forecast for glycomics/glycobiology market?

Answer: The global glycomics/glycobiology market is expected to grow with a CAGR of 14.8% from 2023 to 2028.

Q3. What are the major drivers influencing the growth of the glycomics/glycobiology market?

Answer: The major drivers for this market are increasing research and development activities related to drug discovery along with rising investment by governments and organizations for academic research for development of new glycomics and glycobiology tools.

Q4. What are the major segments for glycomics/glycobiology market?

Answer: The future of the glycomics/glycobiology market looks promising with opportunities in drug discovery & development and disease diagnostics.

Q5. Who are the key glycomics/glycobiology companies?

Answer: Some of the key glycomics/glycobiology companies are as follows:

  • Merck
  • Agilent
  • Thermo Fisher Scientific
  • New England Biolabs
  • Shimadzu
  • Takara Bio
  • S-BIO
  • Waters
  • Asparia Glycomics
  • Bio-Techne

Q6. Which glycomics/glycobiology segment will be the largest in future?

Answer:Lucintel forecasts that drug discovery and development will remain the largest segment over the forecast period due to the increasing research and development activities related to glycomics and proteomics.

Q7. In glycomics/glycobiology market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to increase in government fundings for research and development activities and presence of advanced healthcare infrastructure in the region.

Q8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

  • Q.1. What are some of the most promising, high-growth opportunities for the glycomics/glycobiology market by product (enzymes, instruments, carbohydrates, and reagents & chemicals), application (drug discovery & development, disease diagnostics, and others), end use industry (academic and research institutes, pharmaceutical & biotechnology companies, and clinical laboratories), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Glycomics/Glycobiology Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

  • 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
  • 3.2: Global Glycomics/Glycobiology Market Trends (2017-2022) and Forecast (2023-2028)
  • 3.3: Global Glycomics/ Glycobiology Market by Product
    • 3.3.1: Enzymes
      • 3.3.1.1: Glycosidases & Neuramidases
      • 3.3.1.2: Glycosyltransferases & Sialyltransferases
      • 3.3.1.3: Others
    • 3.3.2: Instruments
      • 3.3.2.1: Mass Spectrometry Instruments
      • 3.3.2.2: Chromatography Instruments
      • 3.3.2.3: Arrays
      • 3.3.2.4: Others
    • 3.3.3: Carbohydrates
      • 3.3.3.1: Oligosaccharides
      • 3.3.3.2: Monosaccharides
      • 3.3.3.3: Others
    • 3.3.4: Reagents & Chemicals
  • 3.4: Global Glycomics/ Glycobiology Market by Application
    • 3.4.1: Drug Discovery & Development
    • 3.4.2: Disease Diagnostics
      • 3.4.2.1: Cancer Diagnostics
      • 3.4.2.2: Other Disease Diagnostics
    • 3.4.3: Other Applications
  • 3.5: Global Glycomics/ Glycobiology Market by End Use Industry
    • 3.5.1: Academic and Research Institutes
    • 3.5.2: Pharmaceutical and Biotechnology Companies
    • 3.5.3: Clinical Laboratories

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

  • 4.1: Global Glycomics/Glycobiology Market by Region
  • 4.2: North American Glycomics/Glycobiology Market
    • 4.2.1: North American Glycomics/ Glycobiology Market by Application: Drug Discovery & Development, Disease Diagnostics, and Others
    • 4.2.2: North American Glycomics/ Glycobiology Market by End Use Industry: Academic and Research Institutes, Pharmaceutical & Biotechnology Companies, and Clinical Laboratories
  • 4.3: European Glycomics/ Glycobiology Market
    • 4.3.1: European Glycomics/ Glycobiology Market by Application: Drug Discovery & Development, Disease Diagnostics, and Others
    • 4.3.2: European Glycomics/ Glycobiology Market by End Use Industry: Academic and Research Institutes, Pharmaceutical & Biotechnology Companies, and Clinical Laboratories
  • 4.4: APAC Glycomics/ Glycobiology Market
    • 4.4.1: APAC Glycomics/ Glycobiology Market by Application: Drug Discovery & Development, Disease Diagnostics, and Others
    • 4.4.2: APAC Glycomics/ Glycobiology Market by End Use Industry: Academic and Research Institutes, Pharmaceutical & Biotechnology Companies, and Clinical Laboratories
  • 4.5: ROW Glycomics/ Glycobiology Market
    • 4.5.1: ROW Glycomics/ Glycobiology Market by Application: Drug Discovery & Development, Disease Diagnostics, and Others
    • 4.5.2: ROW Glycomics/ Glycobiology Market by End Use Industry: Academic and Research Institutes, Pharmaceutical & Biotechnology Companies, and Clinical Laboratories

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Glycomics/ Glycobiology Market by Product
    • 6.1.2: Growth Opportunities for the Global Glycomics/ Glycobiology Market by Application
    • 6.1.3: Growth Opportunities for the Global Glycomics/ Glycobiology Market by End Use Industry
    • 6.1.4: Growth Opportunities for the Global Glycomics/ Glycobiology Market by Region
  • 6.2: Emerging Trends in the Global Glycomics/Glycobiology Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Glycomics/Glycobiology Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Glycomics/Glycobiology Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Merck
  • 7.2: Agilent
  • 7.3: Thermo Fisher Scientific
  • 7.4: New England Biolabs
  • 7.5: Shimadzu
  • 7.6: Takara Bio
  • 7.7: S-BIO
  • 7.8: Waters
  • 7.9: Asparia Glycomics
  • 7.10: Bio-Techne